TNG-908; EX-A7872
Iinkcukacha zeMveliso
Iithegi zeMveliso
| Ubungakanani bePakethe | Ubukho | Ixabiso (USD) |
| 50MG | Ikhona evenkileni | 650 |
| 100MG | Ikhona evenkileni | 850 |
Igama leMchiza:
N-(6-amino-5-methylpyridin-3-yl)-2-((2R,5S)-2-(benzo[d]thiazol-5-yl)-5-methylpiperidin-1-yl)-2- i-oxoacetamide
Ikhowudi yoncumo:
CC1=CC(NC(C(N2[C@@H](C3=CC=C(SC=N4)C4=C3)CC[C@@H](C2)C)=O)=O)=CN =C1N
Ikhowudi ye-InChi:
InChI=1S/C21H23N5O2S/c1-12-3-5-17(14-4-6-18-16(8-14)24-11-29-18)26(10-12)21(28)20( 27)25-1 5-7-13(2)19(22)23-9-15/h4,6-9,11-12,17H,3,5,10H2,1-2H3,(H2,22,23)(H, 25,27)/t12-,17+/m0/s1
Isitshixo se-InChi:
NXXBDYHMHINFC-YVEFUNNKSA-N
Igama elingundoqo:
2760481-53-4;CAS:2760481-53-4;CAS:2760481-53-4;TNG908;TNG-908;TNG 908;EX-A7872;
Ukunyibilika:
Ugcino:Yomile, emnyama kunye ne-0 -4 C kwixesha elifutshane (iintsuku ukuya kwiiveki) okanye -20 C ixesha elide (iinyanga ukuya kwiminyaka).
Inkcazo:
I-TNG908 yi-MTAP synergistic PRMT5 inhibitor.
Ithagethi: PRMT5







![(cis)-tert-butyl 6-oxo-7-oxa-5-azaspiro[3.4]octane-2-carboxylate](http://www.caerulumpharm.com/uploads/微信截图_20220803103831.png)